Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Licensing revenue	$ 0	$ 0	$ 850	$ 0
Research and development	8,612	8,831	29,304	25,694
General and administrative	3,627	3,095	11,597	9,276
Total operating expenses	12,239	11,926	40,901	34,970
Loss from operations	(12,239)	(11,926)	(40,051)	(34,970)
Other income	1,758	1,962	5,709	5,891
Net loss	(10,481)	(9,964)	(34,342)	(29,079)
Unrealized gain (loss) on marketable securities	577	77	449	(128)
Comprehensive loss	$ (9,904)	$ (9,887)	$ (33,893)	$ (29,207)
Net loss per share - basic and diluted (in dollars per share)	$ (0.08)	$ (0.08)	$ (0.25)	$ (0.23)
Basic and diluted weighted average shares outstanding (in shares)	137,589	127,424	137,263	126,837
Net loss	$ (10,481)	$ (9,964)	$ (34,342)	$ (29,079)
Unrealized gain (loss) on marketable securities	577	77	449	(128)
Comprehensive loss	$ (9,904)	$ (9,887)	$ (33,893)	$ (29,207)